Skip to main content

Covista Announces Third Quarter Fiscal Year 2026 Conference Call

Covista (the "company" or "Covista") (NYSE: CVSA), the largest healthcare educator in the United States, announced today it will release its third quarter fiscal year 2026 results on Thursday, May 7, 2026, after market close, followed by a conference call at 4:00 p.m. CT (5:00 p.m. ET) the same day to discuss the results.

This call can be accessed by dialing +1 877-407-6184 (U.S. participants) or +1 201-389-0877 (international participants) and stating “Covista earnings call” or by using conference ID: 13759299. The call will be simulcast through the Covista investor relations website at: https://investors.covista.com. Covista will archive a replay of the call for 30 days. To access the replay, dial +1 877-660-6853 (U.S.) or +1 201-612-7415 (international), conference ID: 13759299, or visit the Covista investor relations website.

About Covista

Covista is America's largest healthcare educator, serving more than 97,000 students and supported by a community of 385,000 alumni across five accredited institutions. Through personalized, tech-enabled education powered by 10,000 faculty and colleagues, Covista expands access to healthcare careers and addresses the U.S. healthcare workforce shortage at scale. Covista is the parent company of American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. For more information, visit covista.com and follow us on LinkedIn, Instagram and YouTube.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.77
+0.00 (0.00%)
AAPL  253.41
-0.09 (-0.04%)
AMD  221.53
+0.00 (0.00%)
BAC  50.28
+0.00 (0.00%)
GOOG  303.93
+0.00 (0.00%)
META  575.05
+0.00 (0.00%)
MSFT  372.29
+0.00 (0.00%)
NVDA  178.10
+0.00 (0.00%)
ORCL  143.17
+0.00 (0.00%)
TSLA  346.65
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.